Lee, Yu Na
Yi, Hye-Jin
Seo, Eun Hye
Oh, Jooyun
Lee, Song
Ferber, Sarah
Okano, Teruo
Shim, In Kyong https://orcid.org/0000-0002-1408-9048
Kim, Song Cheol
Funding for this research was provided by:
Ministry of Education, Science and Technology, Korea (NRF-2017M3A9C6032060)
Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea (2017-615)
National Research Foundation of Korea (NRF-2015K1A4A3046807)
Article History
Received: 19 March 2020
Accepted: 7 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: This animal study was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC No. 2015-12-133) Asan Institute for Life Sciences. The committee abides by the Institute of Laboratory Animal Resources (ILAR) guide. We obtained written informed consent from all the patients who participated in this study. All experiment protocol of human liver cell isolation was carried out according to the guidelines and with the approval of the Institutional Review Board of Asan Medical Center (IRB number: 2014-1182 Seoul, Republic of Korea).
: Not applicable.
: Dr. Teruo Okano is a founder and Director of the Scientific Advisory Board of CellSeed Inc., which has licenses for certain cell sheet-related technologies and patents from Tokyo Women’s Medical University. Ms. Yu Na Lee, Ms. Hye-Jin Yi, Ms. Eun Hye Seo, Ms. Jooyun Oh, Dr. Song Lee, Dr. Sarah Ferber, Dr. In Kyong Shim, and Dr. Song Cheol Kim declare no potential conflict of interest. The authors declare that there are no other financial or non-financial competing interests.